Deep Dive

In the first half of 2026, Sweden’s Lifco spent 928 million kronor buying companies and acquired roughly 110 million kronor […]

In December 2023, adalimumab biosimilars held 79 percent of the German market. In February 2024, they held four percent of

On the evening of August 12, 2026, a committee published a list shortly after 11 p.m. Central European time. It

In the second quarter of 2026, Meta grew revenue 28 percent to $60.8 billion. Net income fell 14 percent. Nothing

In the first half of 2026, executives at US companies sold 77.6 billion dollars of their own stock and bought

In November 2025, Qnity was carved out of DuPont. The stock first fell about twelve percent, then traded at more

In the first quarter of 2026, Alphabet did not repurchase a single share of its own stock for the first

In the summer of 2024, Novo Nordisk was the most valuable company in Europe. Two years later, roughly a quarter

In September 2025, Germany’s Rheinmetall was the stock all of Europe was talking about: from roughly €100 in early 2022

Wall Street has fixated on the wrong shortage. For months investors have fought over every Nvidia chip and every gigabyte